Delivery Order SPE2DB20D1004-SPE2DB25FNKWE
- Not listed
- The Defense Logistics Agency awarded a $1,208.82 firm fixed price delivery order to AmerisourceBergen Drug Corp for Tobradex eye ointment (3.5 grams) on July 14, 2025, with an ultimate completion date of July 15, 2025. This non-set-aside contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for Tobradex Eye Ointment (3.5gm) with a ceiling value of $1,639.13 under a firm fixed-price delivery order contract. This award is a non-set-aside, competitively awarded contract executed through the company's existing Indefinite Delivery Contract with DLA. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for...
- The Defense Logistics Agency awarded a $5,790.67 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Tobradex Eye Ointment (3.5 grams). This firm fixed-price contract, which closes on July 22, 2025, represents a single delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract is non-competitive and does not utilize a set-aside designation. Performance will occur at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,509.39 to AmerisourceBergen Drug Corp for Tobradex eye ointment (3.5 grams) on July 24, 2025, with an ultimate completion date of July 25, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. Performance will be executed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,434.64 to AmerisourceBergen Drug Corp for Tobradex eye ointment (3.5 grams) on September 2, 2025, with an ultimate completion date of September 3, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. Tobradex is a combination ophthalmic medication commonly used for treating eye inflammation and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $6,850.39 to supply Tobradex eye ointment (3.5 grams) under a firm fixed price contract. The award was made on July 3, 2025, with an ultimate completion date of July 7, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This non-set-aside award was competitively awarded to AmerisourceBergen, a major pharmaceutical distributor and critical federal...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,122.06 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corporation's Corporate Office division to supply 4,565,592,515 units of Tobradex eye ointment, 3.5 grams. The contract has an ultimate completion date of August 28, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between DLA Troop Support Medical and AmerisourceBergen, running through December 2025, for a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Tobradex Eye Ointment 3.5 GM. The $3,244.52 firm-fixed-price contract has an ultimate completion date of August 2, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these critical ophthalmic medication supplies to support military treatment facilities and other government healthcare programs. This award is part of a larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,130 to Amerisourcebergen Drug Corporation for Tobradex eye ointment. The order is to be fulfilled by Amerisourcebergen's corporate office in Conshohocken, Pennsylvania and completed within one day, between June 21 and June 22, 2023. As a major distributor of pharmaceuticals and medical supplies to the U.S. Department of Defense, Amerisourcebergen will deliver the requested Tobradex eye ointment in...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $5,418.60 to Amerisourcebergen Drug Corporation for Tobradex eye ointment. As the prime contractor, Amerisourcebergen will deliver 3.5 gram tubes of the ointment to its facility in Conshohocken, Pennsylvania by August 30, 2023 to fulfill requirements under the contract. The parent company, Amerisourcebergen Corporation, will perform the work through its corporate office division. No subcontractors or set aside...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB25FNKWEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,165.39 to AmerisourceBergen Drug Corp for Tobradex eye ointment (3.5 grams) on September 18, 2025, with an ultimate completion date of September 19, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through its comprehensive IDC with the DLA. This prime contract vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. The Tobradex delivery order exemplifies the company's ongoing role in fulfilling routine pharmaceutical supply requirements for defense and military healthcare systems through competitive, firm fixed-price transactions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 9/18/25 |